Tarabykina S, Griffiths T R L, Tulchinsky E, Mellon J K, Bronstein I B, Kriajevska M
Novo Nordisk A/S, Maaloev, Denmark.
Curr Cancer Drug Targets. 2007 May;7(3):217-28. doi: 10.2174/156800907780618329.
S100A4 (also known as Mts1, metastasin, p9Ka, pEL98, CAPL, calvasculin, Fsp-1, placental calcium-binding protein) belongs to the family of EF-hand calcium-binding proteins, whose expression is elevated in a number of pathological conditions. Although it is well documented that S100A4 is expressed in cancer cells and contributes to tumor cell motility and metastatic progression, the exact underlying mechanisms remain elusive. An important characteristic feature of S100 proteins is their dual function, inside and outside the cell. In this review, we focus on the intracellular function of S100A4. The review contains structural analysis of S1004 in comparison with other members of S100 proteins. Possible modes of the interaction of S100 proteins with targets are described. Several examples of best-studied molecular interactions involving S100A4 with heavy chain of nonmuscle myosin IIA, LAR-interacting protein liprin beta1 and tumor suppressor protein p53 are provided. We suggest that the binding of S100A4 to these molecules is critical for the S100A4 function. Further studies of the implications of these interactions in different molecular pathways may shed additional light on the role of S100A4 protein in the control of tumor cell motility and migration. We discuss the approaches for down-regulation of S100A4 expression and their potential for application in the clinics.
S100A4(也称为Mts1、转移抑制因子、p9Ka、pEL98、CAPL、血管平滑肌钙结合蛋白、Fsp-1、胎盘钙结合蛋白)属于EF手型钙结合蛋白家族,其表达在多种病理状态下会升高。尽管有充分的文献记载S100A4在癌细胞中表达,并有助于肿瘤细胞的运动和转移进展,但其确切的潜在机制仍不清楚。S100蛋白的一个重要特征是其在细胞内外的双重功能。在本综述中,我们聚焦于S100A4的细胞内功能。该综述包含了S1004与S100蛋白其他成员的结构分析。描述了S100蛋白与靶标的可能相互作用模式。提供了几个研究得较为透彻的分子相互作用实例,涉及S100A4与非肌肉肌球蛋白IIA重链、LAR相互作用蛋白liprin beta1和肿瘤抑制蛋白p53。我们认为S100A4与这些分子的结合对S100A4的功能至关重要。对这些相互作用在不同分子途径中的影响进行进一步研究,可能会为S100A4蛋白在控制肿瘤细胞运动和迁移中的作用提供更多线索。我们讨论了下调S100A4表达的方法及其在临床应用中的潜力。